Claims
- 1. A method for protecting the eye against senile macular degeneration comprising administering anisodamine or a pharmaceutically-acceptable salt thereof to the eye of a human in need thereof in an amount effective to protect the eye against senile macular degeneration.
- 2. The method of claim 1 wherein anisodamine or the pharmaceutically-acceptable salt thereof is parenterally administered in association with a pharmaceutically-acceptable liquid carrier.
- 3. The method of claim 1 wherein the effective amount administered is about 0.5-50 mg per kilogram body weight, per day.
- 4. The method of claim 1 wherein anisodamine is topically administered.
- 5. The method of claim 1 wherein anisodamine is administered in the form of eyedrops.
CROSS-REFERENCE TO RELATED APPLICATION
This is a division of application Ser. No. 07/296,712, filed Jan. 17, 1989, now U.S. Pat. No. 4,971,976.
This application is a continuation-in-part of U.S. application Ser. No. 153,238, filed Feb. 8, 1988 now abandoned.
Non-Patent Literature Citations (4)
Entry |
Chem. Abst., 110:226915d, (1989), Li et al. |
S. Zhang et al., Pediatric Res. 20,177a, (1986). |
Pharmacologic Effects of Anisodamine, Chines Med. J., 7, 133-138, (1975). |
Fed. Proc., vol. 23, 4, Part 2, May 1988, p. 882. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
296712 |
Jan 1989 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
153238 |
Feb 1988 |
|